Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Valentina Allegro

Showing results (1-10 of 7) with videos related to

Pageof 1
Sort By:
Heart Failure Clinics|June 6, 2024
Specific Therapy in Transthyretin Amyloid Cardiomyopathy: Future Perspectives Beyond TafamidisRiccardo Saro, Valentina Allegro, Marco Merlo, et al.
European Heart Journal Supplements : Journal of the European Society of Cardiology|June 13, 2024
Abnormal conduction-induced cardiomyopathy: a poorly explored entityAndrea Lalario, Maddalena Rossi, Valentina Allegro, et al.
European Heart Journal Supplements : Journal of the European Society of Cardiology|May 8, 2026
Classification of cardiomyopathies: bringing order to complexityMaria Perotto, Carola Pio Loco Detto Gava, Federico Garoia, et al.
Frontiers in Cardiovascular Medicine|November 24, 2022
Evolving trends in epidemiology and natural history of cardiac amyloidosis: 30-year experience from a tertiary referral center for cardiomyopathiesAldostefano Porcari, Valentina Allegro, Riccardo Saro, et al.
European Journal of Heart Failure|March 15, 2023
Left ventricular wall thickness and severity of cardiac disease in women and men with transthyretin amyloidosisAlberto Aimo, Daniela Tomasoni, Aldostefano Porcari, et al.
JAMA Cardiology|January 22, 2025
Clinical Phenotype and Prognosis of Asymptomatic Patients With Transthyretin Cardiac Amyloid InfiltrationAldostefano Porcari, Yousuf Razvi, Francesco Cappelli, et al.
Journal of the American College of Cardiology|June 12, 2024
SGLT2 Inhibitor Therapy in Patients With Transthyretin Amyloid CardiomyopathyAldostefano Porcari, Francesco Cappelli, Christian Nitsche, et al.
Pageof 1

Showing results (1-10 of 7) with videos related to

Sort By:
Pageof 1
Heart Failure Clinics|June 6, 2024
Specific Therapy in Transthyretin Amyloid Cardiomyopathy: Future Perspectives Beyond TafamidisRiccardo Saro, Valentina Allegro, Marco Merlo, et al.
European Heart Journal Supplements : Journal of the European Society of Cardiology|June 13, 2024
Abnormal conduction-induced cardiomyopathy: a poorly explored entityAndrea Lalario, Maddalena Rossi, Valentina Allegro, et al.
European Heart Journal Supplements : Journal of the European Society of Cardiology|May 8, 2026
Classification of cardiomyopathies: bringing order to complexityMaria Perotto, Carola Pio Loco Detto Gava, Federico Garoia, et al.
Frontiers in Cardiovascular Medicine|November 24, 2022
Evolving trends in epidemiology and natural history of cardiac amyloidosis: 30-year experience from a tertiary referral center for cardiomyopathiesAldostefano Porcari, Valentina Allegro, Riccardo Saro, et al.
European Journal of Heart Failure|March 15, 2023
Left ventricular wall thickness and severity of cardiac disease in women and men with transthyretin amyloidosisAlberto Aimo, Daniela Tomasoni, Aldostefano Porcari, et al.
JAMA Cardiology|January 22, 2025
Clinical Phenotype and Prognosis of Asymptomatic Patients With Transthyretin Cardiac Amyloid InfiltrationAldostefano Porcari, Yousuf Razvi, Francesco Cappelli, et al.
Journal of the American College of Cardiology|June 12, 2024
SGLT2 Inhibitor Therapy in Patients With Transthyretin Amyloid CardiomyopathyAldostefano Porcari, Francesco Cappelli, Christian Nitsche, et al.
Pageof 1